Avanos Medical Statistics
Share Statistics
Avanos Medical has 45.96M shares outstanding. The number of shares has increased by -0.53% in one year.
| Shares Outstanding | 45.96M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.02% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 44.82M |
| Failed to Deliver (FTD) Shares | 9 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 727.69K, so 1.58% of the outstanding shares have been sold short.
| Short Interest | 727.69K |
| Short % of Shares Out | 1.58% |
| Short % of Float | 1.62% |
| Short Ratio (days to cover) | 2.54 |
Valuation Ratios
The PE ratio is -16.91 and the forward PE ratio is 11.92.
| PE Ratio | -16.91 |
| Forward PE | 11.92 |
| PS Ratio | 1.55 |
| Forward PS | 1 |
| PB Ratio | 0.85 |
| P/FCF Ratio | 71.59 |
| PEG Ratio | n/a |
Enterprise Valuation
Avanos Medical Inc. has an Enterprise Value (EV) of 1.17B.
| EV / Earnings | -18.88 |
| EV / Sales | 1.73 |
| EV / EBITDA | 23.06 |
| EV / EBIT | 277.77 |
| EV / FCF | 79.91 |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.08 |
| Quick Ratio | 1.38 |
| Debt / Equity | 0.14 |
| Total Debt / Capitalization | 11.96 |
| Cash Flow / Debt | 0.19 |
| Interest Coverage | 0.28 |
Financial Efficiency
Return on equity (ROE) is -0.05% and return on capital (ROIC) is 0.36%.
| Return on Equity (ROE) | -0.05% |
| Return on Assets (ROA) | -0.04% |
| Return on Capital (ROIC) | 0.36% |
| Revenue Per Employee | 178.55K |
| Profits Per Employee | -16.39K |
| Employee Count | 3.77K |
| Asset Turnover | 0.4 |
| Inventory Turnover | 1.8 |
Taxes
| Income Tax | 2.00M |
| Effective Tax Rate | -0.25 |
Stock Price Statistics
The stock price has increased by -17.3% in the last 52 weeks. The beta is 0.93, so Avanos Medical 's price volatility has been higher than the market average.
| Beta | 0.93 |
| 52-Week Price Change | -17.3% |
| 50-Day Moving Average | 17.89 |
| 200-Day Moving Average | 20.5 |
| Relative Strength Index (RSI) | 37.87 |
| Average Volume (20 Days) | 371.53K |
Income Statement
In the last 12 months, Avanos Medical had revenue of 673.30M and earned -61.80M in profits. Earnings per share was -1.33.
| Revenue | 673.30M |
| Gross Profit | 379.70M |
| Operating Income | 4.20M |
| Net Income | -61.80M |
| EBITDA | 50.60M |
| EBIT | 4.20M |
| Earnings Per Share (EPS) | -1.33 |
Balance Sheet
The company has 87.70M in cash and 209.10M in debt, giving a net cash position of -121.40M.
| Cash & Cash Equivalents | 87.70M |
| Total Debt | 209.10M |
| Net Cash | -121.40M |
| Retained Earnings | -314.90M |
| Total Assets | 1.66B |
| Working Capital | 259.70M |
Cash Flow
In the last 12 months, operating cash flow was 32.40M and capital expenditures -17.80M, giving a free cash flow of 14.60M.
| Operating Cash Flow | 32.40M |
| Capital Expenditures | -17.80M |
| Free Cash Flow | 14.60M |
| FCF Per Share | 0.31 |
Margins
Gross margin is 56.39%, with operating and profit margins of 0.62% and -9.18%.
| Gross Margin | 56.39% |
| Operating Margin | 0.62% |
| Pretax Margin | -1.17% |
| Profit Margin | -9.18% |
| EBITDA Margin | 7.52% |
| EBIT Margin | 0.62% |
| FCF Margin | 2.17% |
Dividends & Yields
AVNS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -8.41% |
| FCF Yield | 2.01% |
Analyst Forecast
Currently there are no analyst rating for AVNS.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 1.44 |
| Piotroski F-Score | 6 |